Model-informed safety management of tocilizumab for pediatric sJIA: a PBPK approach for dose-escalation and vaccination timing - Quiz - MDSpire

Model-informed safety management of tocilizumab for pediatric sJIA: a PBPK approach for dose-escalation and vaccination timing

  • By

  • Yujie Yang

  • Rui Wang

  • Zhimin Li

  • Liang Zheng

  • Chaozhuang Shen

  • June 1, 2026

  • 0 min

Share

Original Source(s)

Model-informed safety management of tocilizumab for pediatric sJIA: a PBPK approach for dose-escalation and vaccination timing

  • by Yujie Yang, Rui Wang, Zhimin Li, Liang Zheng, Chaozhuang Shen

  • June 1, 2026

Related Content

From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report

An observational study of quick-relief inhaler storage and use among children with asthma in home, school, and community

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant